Literature DB >> 10918582

Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis.

T L Timme1, A Goltsov, S Tahir, L Li, J Wang, C Ren, R N Johnston, T C Thompson.   

Abstract

Recent data indicating that overexpression of caveolin-1 as well as c-myc are relatively common features of advanced prostate cancer prompted us to test for potential cooperative interactions between caveolin-1 and c-myc that would be consistent with malignant progression. We used the well-characterized Rat1AmycERT cells to show that the caveolin-1 gene is down-regulated at the level of transcription by c-myc. By maintaining relatively high levels of caveolin-1 with an adenoviral vector or in stably transfected clones we show that caveolin-1 can suppress c-myc-induced apoptosis. Further we established human prostate cancer cell lines with the mycER construct and show that clones with increased caveolin-1 are more resistant to myc-induced apoptosis and have increased capacity for growth in soft agar when c-myc is activated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918582     DOI: 10.1038/sj.onc.1203654

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Guang Yang; Alexei A Goltsov; Chengzhen Ren; Shinji Kurosaka; Kohei Edamura; Richard Logothetis; Francesco J DeMayo; Patricia Troncoso; Jorge Blando; John DiGiovanni; Timothy C Thompson
Journal:  Mol Cancer Res       Date:  2011-12-05       Impact factor: 5.852

2.  Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1.

Authors:  Feng Dong; Xiaochun Zhang; Loren E Wold; Qun Ren; Zhaojie Zhang; Jun Ren
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Distribution of caveolin-1 and connexin43 in normal and injured alveolar epithelial R3/1 cells.

Authors:  K Barth; M Gentsch; R Bläsche; A Pfüller; I Parshyna; R Koslowski; G Barth; M Kasper
Journal:  Histochem Cell Biol       Date:  2004-11-20       Impact factor: 4.304

4.  Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc.

Authors:  Upal K Basu Roy; Rebecca S Henkhaus; Natalia A Ignatenko; Jessica Mora; Kimberly E Fultz; Eugene W Gerner
Journal:  Mol Carcinog       Date:  2008-12       Impact factor: 4.784

5.  Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation.

Authors:  Chao-Chi Ho; Pei-Hsin Huang; Hsin-Yi Huang; Yen-Ho Chen; Pan-Chyr Yang; Su-Ming Hsu
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.

Authors:  Zhi Zhao; Fang-Hai Han; Shi-Bin Yang; Li-Xin Hua; Jian-Hai Wu; Wen-Hua Zhan
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

7.  Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas.

Authors:  K Wiechen; C Sers; A Agoulnik; K Arlt; M Dietel; P M Schlag; U Schneider
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

8.  Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts.

Authors:  Daniela Volonte; Kun Zhang; Michael P Lisanti; Ferruccio Galbiati
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

9.  Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1.

Authors:  Pithi Chanvorachote; Ubonthip Nimmannit; Yongju Lu; Siera Talbott; Bing-Hua Jiang; Yon Rojanasakul
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

10.  Apoptosis of lens epithelial cells induced by high concentration of glucose is associated with a decrease in caveolin-1 levels.

Authors:  Zhiyong Zhang; Ke Yao; Chongfei Jin
Journal:  Mol Vis       Date:  2009-09-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.